v3.25.2
Fair Value Measurements - Schedule of Fair Value of Assets and Liabilities Measured on a Recurring Basis (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Derivatives Not Designated as Hedging Instruments:    
Assets:    
Derivative asset $ 32,334 $ 27,097
Liabilities:    
Derivative liability 49,462 54,734
Fair Value, Recurring    
Assets:    
Investment with readily determinable fair value   10,144
Total assets 32,334 37,241
Liabilities:    
Total liabilities 137,389 138,952
Fair Value, Recurring | Current contingent consideration    
Liabilities:    
ImThera contingent consideration arrangement 48,265  
Fair Value, Recurring | Long-term contingent consideration    
Liabilities:    
ImThera contingent consideration arrangement 39,662 84,218
Fair Value, Recurring | Embedded Derivatives | 2025 Notes    
Liabilities:    
Derivative liability 1,363  
Fair Value, Recurring | Embedded Derivatives | 2029 Notes    
Liabilities:    
Derivative liability 48,093 51,819
Fair Value, Recurring | Derivatives Not Designated as Hedging Instruments: | Freestanding Instruments (FX)    
Assets:    
Derivative asset 9,373 738
Fair Value, Recurring | Derivatives Not Designated as Hedging Instruments: | Capped Call Derivatives | 2025 Notes    
Assets:    
Derivative asset 1,303 2,624
Fair Value, Recurring | Derivatives Not Designated as Hedging Instruments: | Capped Call Derivatives | 2029 Notes    
Assets:    
Derivative asset 21,658 23,735
Fair Value, Recurring | Designated as Hedging Instrument | Freestanding Instruments (FX)    
Liabilities:    
Derivative liability 6  
Fair Value, Recurring | Designated as Hedging Instrument | Embedded Derivatives | 2025 Notes    
Liabilities:    
Derivative liability   2,915
Fair Value, Recurring | Level 1    
Assets:    
Investment with readily determinable fair value   10,144
Total assets 0 10,144
Liabilities:    
Total liabilities 0 0
Fair Value, Recurring | Level 1 | Current contingent consideration    
Liabilities:    
ImThera contingent consideration arrangement 0  
Fair Value, Recurring | Level 1 | Long-term contingent consideration    
Liabilities:    
ImThera contingent consideration arrangement 0 0
Fair Value, Recurring | Level 1 | Embedded Derivatives | 2025 Notes    
Liabilities:    
Derivative liability 0  
Fair Value, Recurring | Level 1 | Embedded Derivatives | 2029 Notes    
Liabilities:    
Derivative liability 0 0
Fair Value, Recurring | Level 1 | Derivatives Not Designated as Hedging Instruments: | Freestanding Instruments (FX)    
Assets:    
Derivative asset 0 0
Fair Value, Recurring | Level 1 | Derivatives Not Designated as Hedging Instruments: | Capped Call Derivatives | 2025 Notes    
Assets:    
Derivative asset 0 0
Fair Value, Recurring | Level 1 | Derivatives Not Designated as Hedging Instruments: | Capped Call Derivatives | 2029 Notes    
Assets:    
Derivative asset 0 0
Fair Value, Recurring | Level 1 | Designated as Hedging Instrument | Freestanding Instruments (FX)    
Liabilities:    
Derivative liability 0  
Fair Value, Recurring | Level 1 | Designated as Hedging Instrument | Embedded Derivatives | 2025 Notes    
Liabilities:    
Derivative liability   0
Fair Value, Recurring | Level 2    
Assets:    
Investment with readily determinable fair value   0
Total assets 9,373 738
Liabilities:    
Total liabilities 6 0
Fair Value, Recurring | Level 2 | Current contingent consideration    
Liabilities:    
ImThera contingent consideration arrangement 0  
Fair Value, Recurring | Level 2 | Long-term contingent consideration    
Liabilities:    
ImThera contingent consideration arrangement 0 0
Fair Value, Recurring | Level 2 | Embedded Derivatives | 2025 Notes    
Liabilities:    
Derivative liability 0  
Fair Value, Recurring | Level 2 | Embedded Derivatives | 2029 Notes    
Liabilities:    
Derivative liability 0 0
Fair Value, Recurring | Level 2 | Derivatives Not Designated as Hedging Instruments: | Freestanding Instruments (FX)    
Assets:    
Derivative asset 9,373 738
Fair Value, Recurring | Level 2 | Derivatives Not Designated as Hedging Instruments: | Capped Call Derivatives | 2025 Notes    
Assets:    
Derivative asset 0 0
Fair Value, Recurring | Level 2 | Derivatives Not Designated as Hedging Instruments: | Capped Call Derivatives | 2029 Notes    
Assets:    
Derivative asset 0 0
Fair Value, Recurring | Level 2 | Designated as Hedging Instrument | Freestanding Instruments (FX)    
Liabilities:    
Derivative liability 6  
Fair Value, Recurring | Level 2 | Designated as Hedging Instrument | Embedded Derivatives | 2025 Notes    
Liabilities:    
Derivative liability   0
Fair Value, Recurring | Level 3    
Assets:    
Investment with readily determinable fair value   0
Total assets 22,961 26,359
Liabilities:    
Total liabilities 137,383 138,952
Fair Value, Recurring | Level 3 | Current contingent consideration    
Liabilities:    
ImThera contingent consideration arrangement 48,265  
Fair Value, Recurring | Level 3 | Long-term contingent consideration    
Liabilities:    
ImThera contingent consideration arrangement 39,662 84,218
Fair Value, Recurring | Level 3 | Embedded Derivatives | 2025 Notes    
Liabilities:    
Derivative liability 1,363  
Fair Value, Recurring | Level 3 | Embedded Derivatives | 2029 Notes    
Liabilities:    
Derivative liability 48,093 51,819
Fair Value, Recurring | Level 3 | Derivatives Not Designated as Hedging Instruments: | Freestanding Instruments (FX)    
Assets:    
Derivative asset 0 0
Fair Value, Recurring | Level 3 | Derivatives Not Designated as Hedging Instruments: | Capped Call Derivatives | 2025 Notes    
Assets:    
Derivative asset 1,303 2,624
Fair Value, Recurring | Level 3 | Derivatives Not Designated as Hedging Instruments: | Capped Call Derivatives | 2029 Notes    
Assets:    
Derivative asset 21,658 23,735
Fair Value, Recurring | Level 3 | Designated as Hedging Instrument | Freestanding Instruments (FX)    
Liabilities:    
Derivative liability $ 0  
Fair Value, Recurring | Level 3 | Designated as Hedging Instrument | Embedded Derivatives | 2025 Notes    
Liabilities:    
Derivative liability   $ 2,915